The involvement of IL-10, IL-6, IFN-gamma, TNF-alpha and TGF-beta gene polymorphisms among Turkish lung cancer patients
dc.contributor.author | Baştürk, Bilkay | |
dc.contributor.buuauthor | Çolakoğulları, Mukaddes | |
dc.contributor.buuauthor | Ulukaya, Engin | |
dc.contributor.buuauthor | Oral, Arzu Yılmaztepe | |
dc.contributor.buuauthor | Aymak, Figen | |
dc.contributor.buuauthor | Ursavaş, Ahmet | |
dc.contributor.buuauthor | Oral, Haluk Barbaros | |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Biyokimya Anabilim Dalı. | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Göğüs Hastalıkları ve Tüberküloz Anabilim Dalı. | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Mikrobiyoloji ve Enfeksiyon Hastalıkları Anabilim Dalı. | tr_TR |
dc.contributor.orcid | 0000-0003-0463-6818 | tr_TR |
dc.contributor.orcid | 0000-0003-0463-6818 | tr_TR |
dc.contributor.researcherid | A-5841-2017 | tr_TR |
dc.contributor.researcherid | K-7285-2012 | tr_TR |
dc.contributor.researcherid | K-5792-2018 | tr_TR |
dc.contributor.researcherid | AAI-3169-2021 | tr_TR |
dc.contributor.scopusid | 14423975800 | tr_TR |
dc.contributor.scopusid | 6602927353 | tr_TR |
dc.contributor.scopusid | 23091316500 | tr_TR |
dc.contributor.scopusid | 16645073100 | tr_TR |
dc.contributor.scopusid | 8329319900 | tr_TR |
dc.contributor.scopusid | 16645073100 | tr_TR |
dc.date.accessioned | 2021-12-07T11:53:22Z | |
dc.date.available | 2021-12-07T11:53:22Z | |
dc.date.issued | 2008-04 | |
dc.description.abstract | Several genes encoding different cytokines may play crucial roles in host susceptibility to lung cancer, since cytokine production capacity varies among individuals and depends on cytokine gene polymorphisms. The association between cytokine gene polymorphisms with primary lung carcinoma was investigated. DNA samples were obtained from a Turkish population of 44 patients with primary lung cancer, and 59 healthy control subjects. All genotyping (IFN-gamma, TGF-beta 1, TNF-alpha, IL-6 and IL-10) experiments were performed using sequence-specific primers (SSP)-PCR. When compared to the healthy controls, the frequencies of high/intermediate producing genotypes of IL-10 and low producing genotype of TNF-a were significantly more common in the patient group. It is noteworthy that lung cancer patients with the TGF-beta T/T genotype in codon 10 had statistically longer survival compared to those having the C/C genotype (Kaplan-Meier survival function test, log rank significance = 0.014). These results suggest that IL-10, TNF-alpha and TGF-beta 1 gene polymorphisms may affect host susceptibility to lung cancer and the outcome of the patients. | en_US |
dc.identifier.citation | Çolakoğulları, M. vd. (2008). ''The involvement of IL-10, IL-6, IFN-gamma, TNF-alpha and TGF-beta gene polymorphisms among Turkish lung cancer patients''. Cell Biochemistry and Function, 26(3), 283-290. | en_US |
dc.identifier.endpage | 290 | tr_TR |
dc.identifier.issn | 0263-6484 | |
dc.identifier.issn | 1099-0844 | |
dc.identifier.issue | 3 | tr_TR |
dc.identifier.pubmed | 17654453 | tr_TR |
dc.identifier.scopus | 2-s2.0-42949163067 | tr_TR |
dc.identifier.startpage | 283 | tr_TR |
dc.identifier.uri | https://doi.org/10.1002/cbf.1419 | |
dc.identifier.uri | https://onlinelibrary.wiley.com/doi/10.1002/cbf.1419 | |
dc.identifier.uri | http://hdl.handle.net/11452/23047 | |
dc.identifier.volume | 26 | tr_TR |
dc.identifier.wos | 000255433300001 | |
dc.indexed.pubmed | Pubmed | en_US |
dc.indexed.scopus | Scopus | tr_TR |
dc.indexed.wos | SCIE | en_US |
dc.language.iso | en | en_US |
dc.publisher | Wiley | en_US |
dc.relation.collaboration | Yurt içi | tr_TR |
dc.relation.journal | Cell Biochemistry and Function | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | tr_TR |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Tumor-necrosis-factor | en_US |
dc.subject | Tgf-beta-1gene | en_US |
dc.subject | Human-disease | en_US |
dc.subject | Serum-levels | en_US |
dc.subject | Cytokine | en_US |
dc.subject | Inflammation | en_US |
dc.subject | Promoter | en_US |
dc.subject | Receptors | en_US |
dc.subject | Prognosis | en_US |
dc.subject | Risk | en_US |
dc.subject | Biochemistry & molecular biology | en_US |
dc.subject | Cell biology | en_US |
dc.subject | Cytokine | en_US |
dc.subject | Genotyping | en_US |
dc.subject | Lung cancer | en_US |
dc.subject | Single nucleotide gene polymorphism (SNP) | en_US |
dc.subject.emtree | Cisplatin | en_US |
dc.subject.emtree | Etoposide | en_US |
dc.subject.emtree | Gemcitabine | en_US |
dc.subject.emtree | Interleukin 10 | en_US |
dc.subject.emtree | Interleukin 6 | en_US |
dc.subject.emtree | Transforming growth factor beta | en_US |
dc.subject.emtree | Tumor necrosis factor alpha | en_US |
dc.subject.emtree | Transforming growth factor beta | en_US |
dc.subject.emtree | Adult | en_US |
dc.subject.emtree | Article | en_US |
dc.subject.emtree | Cancer patient | en_US |
dc.subject.emtree | Cancer survival | en_US |
dc.subject.emtree | Clinical article | en_US |
dc.subject.emtree | Controlled study | en_US |
dc.subject.emtree | DNA determination | en_US |
dc.subject.emtree | Female | en_US |
dc.subject.emtree | Genetic polymorphism | en_US |
dc.subject.emtree | Genotype | en_US |
dc.subject.emtree | Host susceptibility | en_US |
dc.subject.emtree | Human | en_US |
dc.subject.emtree | Kaplan meier method | en_US |
dc.subject.emtree | Log rank test | en_US |
dc.subject.emtree | Lung cancer | en_US |
dc.subject.emtree | Male | en_US |
dc.subject.emtree | Outcome assessment | en_US |
dc.subject.emtree | Priority journal | en_US |
dc.subject.emtree | Statistical significance | en_US |
dc.subject.emtree | Turkey (republic) | en_US |
dc.subject.mesh | Adult | en_US |
dc.subject.mesh | Alleles | en_US |
dc.subject.mesh | Case-control studies | en_US |
dc.subject.mesh | Codon | en_US |
dc.subject.mesh | Continental population groups | en_US |
dc.subject.mesh | Cytokines | en_US |
dc.subject.mesh | Female | en_US |
dc.subject.mesh | Gene frequency | en_US |
dc.subject.mesh | Genotype | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Interferon type II | en_US |
dc.subject.mesh | Interleukin-10 | en_US |
dc.subject.mesh | Interleukin-6 | en_US |
dc.subject.mesh | Lung neoplasms | en_US |
dc.subject.mesh | Male | en_US |
dc.subject.mesh | Middle aged | en_US |
dc.subject.mesh | Phenotype | en_US |
dc.subject.mesh | Polymorphism regression analysis | en_US |
dc.subject.mesh | Genetic | en_US |
dc.subject.mesh | Regression analysis | en_US |
dc.subject.mesh | Survival analysis | en_US |
dc.subject.mesh | Transforming growth factor beta | en_US |
dc.subject.mesh | Tumor necrosis factor-alpha | en_US |
dc.subject.mesh | Turkey | en_US |
dc.subject.scopus | Transforming Growth Factor Beta1; Restriction Fragment Length Polymorphisms; Polymorphism | en_US |
dc.subject.wos | Biochemistry & molecular biology | en_US |
dc.subject.wos | Cell biology | en_US |
dc.title | The involvement of IL-10, IL-6, IFN-gamma, TNF-alpha and TGF-beta gene polymorphisms among Turkish lung cancer patients | en_US |
dc.type | Article | |
dc.wos.quartile | Q4 | en_US |
Files
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: